Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of Interferon Research
|
October 1, 1991
Interferon stimulates the expression of 2',5'-oligoadenylate synthetase and MHC class I antigens in insulin-producing cells
V Bonnevie-Nielsen, A M Gerdes, J Fleckner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus
B K Michelsen, J S Petersen, E Boel, et al.
Current Problems in Clinical Biochemistry
|
January 1, 1983
Role of islet cell antibodies in the pathogenesis of type I diabetes
C H Brogren, S Baekkeskov, T Dyrberg, et al.
Diabetologia
|
June 1, 1993
Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID)
J S Petersen, M O Marshall, S Baekkeskov, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 24, 1997
Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status
C Jaeger, J Allendörfer, E Hatziagelaki, et al.
Chinese Medical Journal
|
October 17, 2001
Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults
Z Zhou, L Ouyang, J Peng, et al.
Autoimmunity
|
January 1, 1997
Treatment with GAD65 or BSA does not protect against diabetes in BB rats
J S Petersen, P Mackay, A Plesner, et al.
Diabetes
|
November 1, 1994
Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group
J S Petersen, T Dyrberg, A E Karlsen, et al.
Diabetes
|
September 1, 1994
High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy
M M Zanone, J S Petersen, M Peakman, et al.
Diabetologia
|
June 17, 1998
Regulation of GAD expression in rat pancreatic islets and brain by gamma-vinyl-GABA and glucose
J S Petersen, K Rimvall, P N Jørgensen, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of Interferon Research
|
October 1, 1991
Interferon stimulates the expression of 2',5'-oligoadenylate synthetase and MHC class I antigens in insulin-producing cells
V Bonnevie-Nielsen, A M Gerdes, J Fleckner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus
B K Michelsen, J S Petersen, E Boel, et al.
Current Problems in Clinical Biochemistry
|
January 1, 1983
Role of islet cell antibodies in the pathogenesis of type I diabetes
C H Brogren, S Baekkeskov, T Dyrberg, et al.
Diabetologia
|
June 1, 1993
Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID)
J S Petersen, M O Marshall, S Baekkeskov, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 24, 1997
Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status
C Jaeger, J Allendörfer, E Hatziagelaki, et al.
Chinese Medical Journal
|
October 17, 2001
Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults
Z Zhou, L Ouyang, J Peng, et al.
Autoimmunity
|
January 1, 1997
Treatment with GAD65 or BSA does not protect against diabetes in BB rats
J S Petersen, P Mackay, A Plesner, et al.
Diabetes
|
November 1, 1994
Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group
J S Petersen, T Dyrberg, A E Karlsen, et al.
Diabetes
|
September 1, 1994
High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy
M M Zanone, J S Petersen, M Peakman, et al.
Diabetologia
|
June 17, 1998
Regulation of GAD expression in rat pancreatic islets and brain by gamma-vinyl-GABA and glucose
J S Petersen, K Rimvall, P N Jørgensen, et al.
Page
of 8